NYXH · Nyxoah SA
United States · RS rating 6 · As of 2026-11-03
| Price | 0.87 USD |
|---|---|
| 1-day change | -1.1% |
| RS rating (overall / 1M / 3M / 12M) | 6 / 7 / 15 / 8 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 24 / 7 / 21 |
| Industry group (rank) | Medical-Products (106) |
| EPS growth Q/Q | +7.0% |
| Sales growth Q/Q | +186.2% |
| Distance from 52-week high | +85.2% |
| Market cap (USD) | $133.6M |